共 77 条
[1]
Jiang Y(2003)Recombinant human parathyroid hormone (1–34) [teriparatide] improves both cortical and cancellous bone structure J Bone Miner Res 18 1932-1941
[2]
Zhao JJ(2005)Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial J Clin Endocrinol Metab 90 4644-4649
[3]
Mitlak BH(2003)Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment J Clin Endocrinol Metab 88 1150-1156
[4]
Paschalis EP(2006)Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis J Bone Miner Res 21 855-864
[5]
Glass EV(2006)A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide J Bone Miner Res 21 366-373
[6]
Donley DW(2007)The effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis J Bone Miner Res 22 149-157
[7]
Misof BM(2001)Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 1434-1441
[8]
Roschger P(2005)Teriparatide, osteoporosis, calcium, and vitamin D N Engl J Med 353 634-635
[9]
Cosman F(2004)Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate J Bone Miner Res 19 745-751
[10]
Ma YL(2003)The effect of teriparatide [human parathyroid hormone (1–34)] therapy on bone mineral density in men with osteoporosis J Bone Miner Res 18 9-17